Company intelligence / Profile preview
Adeptio Pharmaceuticals
London, England, United Kingdomadeptiopharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Adeptio Pharmaceuticals has a robust clinical pipeline with 78 clinical-stage projects, including 32 programs in Phase 3 or regulatory submission. Their portfolio covers both new molecular entities and expanded indications for existing therapies, primarily focused on difficult-to-treat diseases and immunization. The company has active programs in immunology, neurology, and vaccines, with several candidates advancing in late-stage clinical trials. No commercial launches were referenced.
- Therapeutic areas
- NeurologyPulmonologyInfectious DiseasesDermatologyImmunology
- Modalities
- Small moleculeBiologicVaccine
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Adeptio Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adeptio Pharmaceuticals.